UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

The formation of a somatic mutation in the HLA‐B gene throughout the development of the disease from severe aplastic anaemia to acute myeloid leukaemia

HLA, 2019-12, Vol.94 (S2), p.30-33

2019

Link zum Volltext

Verfügbarkeit prüfen

Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment

Cancer genetics, 2015-04, Vol.208 (4), p.156-161

2015

Link zum Volltext

Verfügbarkeit prüfen

ABC transporters are predictors of treatment failure in acute myeloid leukaemia

Biomedicine & pharmacotherapy, 2024-01, Vol.170, p.115930-115930, Article 115930

2024

Link zum Volltext

Verfügbarkeit prüfen

Hypoplastic form of myelodysplastic neoplasm

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2023, Vol.36 (3), p.206

2023

Link zum Volltext

Verfügbarkeit prüfen

Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome

Experimental hematology, 2009-03, Vol.37 (3), p.386-394

2009

Link zum Volltext

Verfügbarkeit prüfen

Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms

International journal of hematology, 2016-11, Vol.104 (5), p.566-573

2016

Link zum Volltext

Verfügbarkeit prüfen

Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review)

International journal of oncology, 2022-01, Vol.60 (1), p.1, Article 7

2022

Link zum Volltext

Verfügbarkeit prüfen

Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1

Molecular oncology, 2023-12, Vol.17 (12), p.2565-2583

2023

Link zum Volltext

Verfügbarkeit prüfen

LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome

Cancers, 2020-10, Vol.12 (10), p.2726

2020

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients

Pharmaceuticals (Basel, Switzerland), 2021-01, Vol.14 (1), p.41

2021

Link zum Volltext

Verfügbarkeit prüfen

Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome

Cells (Basel, Switzerland), 2020-03, Vol.9 (4), p.794

2020

Link zum Volltext

Verfügbarkeit prüfen

Differential expression of microRNAs in CD34+ cells of 5q- syndrome

Journal of hematology and oncology, 2011-01, Vol.4 (1), p.1-1, Article 1

2011

Link zum Volltext

Verfügbarkeit prüfen

The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia

Leukemia research, 2005-04, Vol.29 (4), p.371-379

2005

Link zum Volltext

Verfügbarkeit prüfen

Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Cells (Basel, Switzerland), 2018-09, Vol.7 (9), p.138

2018

Link zum Volltext

Verfügbarkeit prüfen

Hemoglobinopathies

Vnitřní lékar̆stvĭ, 2018, Vol.64 (5), p.476-487

2018

Link zum Volltext

Verfügbarkeit prüfen

Malignancies and MDS in Patients with Diamond-Blackfan Anemia (DBA) from the Czech National DBA Registry

Blood, 2019-11, Vol.134 (Supplement_1), p.5017-5017

2019

Link zum Volltext

Verfügbarkeit prüfen

DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population

Journal of hematology and oncology, 2013-01, Vol.6 (1), p.9-9, Article 9

2013

Link zum Volltext

Verfügbarkeit prüfen

Changes of Transcriptomic Landscape in Blasts of Responding and Refractory Acute Myeloid Leukemia Patients after Chemotherapy

Blood, 2022-11, Vol.140 (Supplement 1), p.9130-9131

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk Assessment in Patients with Myelodysplastic Neoplasms Using the Molecular International Prognostic Scoring System: A Single-Center Study from the Czech Republic

Blood, 2022-11, Vol.140 (Supplement 1), p.4098-4099

2022

Link zum Volltext

Verfügbarkeit prüfen

Aging-Related Gene Expression Signatures Define Likelihood of Disease Progression in Patients with Lower-Risk Myelodysplastic Syndromes

Blood, 2022-11, Vol.140 (Supplement 1), p.4020-4021

2022

Link zum Volltext

Verfügbarkeit prüfen

Upregulation of ZEB1-Derived Circular RNAs Is Associated with SF3B1-Mutated Myelodysplastic Neoplasms

Blood, 2022-11, Vol.140 (Supplement 1), p.4005-4006

2022

Link zum Volltext

Verfügbarkeit prüfen

Lenalidomide treatment in myelodysplastic syndrome with 5q deletion--Czech MDS group experience

Vnitřní lékar̆stvĭ, 2015-12, Vol.61 (12), p.1028-1033

2015

Link zum Volltext

Verfügbarkeit prüfen

Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower‐risk myelodysplastic neoplasms

International journal of cancer, 2024-05, Vol.154 (9), p.1652-1668

2024

Link zum Volltext

Verfügbarkeit prüfen

Targeting of SFK and G6PD Contributes to Anti-Leukemic Activity of Novel FLT3 Trisubstituted Purine Inhibitors: Effective Therapeutic Approach for AML with FLT3 Mutations

Blood, 2022-11, Vol.140 (Supplement 1), p.8823-8824

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(72)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Humans
(30)
Oncology
(22)
Hematology
(19)
Myelodysplastic Syndromes - Genetics
(19)
Female
(18)
Myelodysplastic Syndrome
(17)
Male
(16)
Myelodysplastic Syndromes
(15)
Adult
(12)
Aged
(12)
Middle Aged
(11)
Bone Marrow
(9)
Gene Expression Profiling
(9)
Mutation
(9)
Cd34 Antigen
(8)
Gene Expression
(8)
Myelodysplastic Syndromes - Pathology
(8)
Prognosis
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The formation of a somatic mutation in the HLA‐B gene throughout the development of the disease from severe aplastic anaemia to acute myeloid leukaemia

Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment

ABC transporters are predictors of treatment failure in acute myeloid leukaemia

Hypoplastic form of myelodysplastic neoplasm

Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome

Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms

Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review)

Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1

LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome

Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients

Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome

Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34 + Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients

Differential expression of microRNAs in CD34+ cells of 5q- syndrome

The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia

Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Hemoglobinopathies

Malignancies and MDS in Patients with Diamond-Blackfan Anemia (DBA) from the Czech National DBA Registry

DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population

Changes of Transcriptomic Landscape in Blasts of Responding and Refractory Acute Myeloid Leukemia Patients after Chemotherapy

Risk Assessment in Patients with Myelodysplastic Neoplasms Using the Molecular International Prognostic Scoring System: A Single-Center Study from the Czech Republic

Aging-Related Gene Expression Signatures Define Likelihood of Disease Progression in Patients with Lower-Risk Myelodysplastic Syndromes

Upregulation of ZEB1-Derived Circular RNAs Is Associated with SF3B1-Mutated Myelodysplastic Neoplasms

Lenalidomide treatment in myelodysplastic syndrome with 5q deletion--Czech MDS group experience

Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower‐risk myelodysplastic neoplasms

Targeting of SFK and G6PD Contributes to Anti-Leukemic Activity of Novel FLT3 Trisubstituted Purine Inhibitors: Effective Therapeutic Approach for AML with FLT3 Mutations

Suchergebnisse filtern